SCHEMBL28359221

SCHEMBL28359221

COCCn1cc(Nc2cc(-c3c(F)cccc3F)nnc2C(N)=O)cn1

nearest known ligand 0.52

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 19/20 0.52
▸ JAK1 P23458 17/20 0.52
▸ JAK2 O60674 16/20 0.52
▸ TYK2 P29597 7/20 0.47
▸ PIM1 P11309 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359207 0.92 JAK3 (0.47) JAK3JAK1JAK2TYK2PIM1
SCHEMBL28359056 0.92 JAK3 (0.47) JAK3JAK1JAK2TYK2PIM1
SCHEMBL29922895 0.92 JAK3 (0.47) JAK3JAK1JAK2TYK2PIM1
SCHEMBL28362626 0.83 JAK1 (0.49) JAK3JAK1JAK2TYK2PIM1
SCHEMBL28359066 0.80 TYK2 (0.49) JAK3JAK1JAK2TYK2PIM1
SCHEMBL29922798 0.80 JAK3 (0.52) JAK3JAK1JAK2TYK2PIM1
SCHEMBL29552173 0.79 TYK2 (0.48) JAK3JAK1JAK2TYK2PIM1
SCHEMBL28362822 0.76 JAK2 (0.54) JAK3JAK1JAK2TYK2
SCHEMBL29551888 0.76 JAK2 (0.59) JAK3JAK1JAK2TYK2
SCHEMBL29552369 0.75 JAK2 (0.55) JAK3JAK1JAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110818641-B Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2022-10-14 — — CN disclosed
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
CN-110818641-A Pyridazine-3-formamide compound, preparation method and application thereof in medicine and pharmacology 北京诺诚健华医药科技有限公司 2020-02-21 — — CN disclosed
Send feedback